Vaccine Distribution

Lord Campbell-Savours Excerpts

Thursday 6th January 2022 Lords Chamber

Asked by

[Lord Campbell-Savours]

To ask Her Majesty’s Government what discussions they have had in the last month with vaccine manufacturers on vaccine distribution.

[The Minister of State, Foreign, Commonwealth and Development Office (Lord Ahmad of Wimbledon) (Con)]

My Lords, the Vaccine Taskforce is in constant communication with vaccine manufacturers to carefully manage UK vaccine supply. Due to commercial sensitivities, we are unable to comment on the details of these discussions. The UK manages our vaccine supply so that all procured doses are either used in the domestic programme or shared internationally. We continue to ensure that any vaccine that the UK does not need is, wherever possible, reallocated to other countries that require it.

[Lord Campbell-Savours (Lab) [V]]

My Lords, how do we justify a vaccination programme that leaves the third world innocently unable to stop disease spread to the unvaccinated in the developed world? If the answer is vaccine supply shortage on the one hand and refusenik human rights on the other, then why not respond by challenging patents, increasing vaccine manufacture and now, while resisting mandatory vaccination, selectively isolating refuseniks where they risk spreading the disease? Or is it that refusenik rights outweigh those of the vulnerable millions who are now forced to work from home, as I am having to do, as the disease spreads?

[Lord Ahmad of Wimbledon (Con)]

My Lords, it is important to recognise that, as has been said repeatedly, there is a global response to this; that is why the UK led on supporting the COVAX Facility. The noble Lord refers to the developing part of the world, and he will be aware, for example, of the additional donations promised by the Prime Minister. Some 20% are going bilaterally, and this includes countries such as Angola, Antigua and Barbuda, Jamaica and Mozambique. We are also working on technical support, which has ensured the manufacture of vaccines within, for example, South Africa.